Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management.

Abstract:

DISEASE OVERVIEW:The myelodysplastic syndromes (MDS) are a very heterogeneous group of myeloid disorders characterized by peripheral blood cytopenias and increased risk of transformation to acute myelogenous leukemia (AML). MDS occurs more frequently in older males and in individuals with prior exposure to cytotoxic therapy. DIAGNOSIS:Diagnosis of MDS is based on morphological evidence of dysplasia upon visual examination of a bone marrow aspirate and biopsy. Information obtained from additional studies such as karyotype, flow cytometry, or molecular genetics is complementary but not diagnostic. Risk-stratification: Prognosis of patients with MDS can be calculated using a number of scoring systems. In general, all these scoring systems include analysis of peripheral cytopenias, percentage of blasts in the bone marrow, and cytogenetic characteristics. The most commonly used system still is probably the International Prognostic Scoring System (IPSS). IPSS is being replaced by the new revised score IPSS-R. RISK-ADAPTED THERAPY:Therapy is selected based on risk, transfusion needs, percent of bone marrow blasts, and more recently cytogenetic and mutational profiles. Goals of therapy are different in lower risk patients than in higher risk. In lower risk, the goal is to decrease transfusion needs and transformation to higher risk disease or AML, as well as to improve survival. In higher risk, the goal is to prolong survival. Current available therapies include growth factor support, lenalidomide, hypomethylating agents, intensive chemotherapy, and allogeneic stem cell transplantation. The use of lenalidomide has significant clinical activity in patients with lower risk disease, anemia, and a chromosome 5 alteration. 5-Azacitidine and decitabine have activity in higher risk MDS. 5-Azacitidine has been shown to improve survival in higher risk MDS. A number of new molecular lesions have been described in MDS that may serve as new therapeutic targets or aid in the selection of currently available agents. Additional supportive care measures may include the use of prophylactic antibiotics and iron chelation. Management of progressive or refractory disease: At the present time there are no approved interventions for patients with progressive or refractory disease particularly after hypomethylating based therapy. Options include participation in a clinical trial or cytarabine based therapy and stem cell transplantation.

journal_name

Am J Hematol

authors

Garcia-Manero G

doi

10.1002/ajh.24102

subject

Has Abstract

pub_date

2015-09-01 00:00:00

pages

831-41

issue

9

eissn

0361-8609

issn

1096-8652

journal_volume

90

pub_type

杂志文章,评审
  • Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.

    abstract::Severe chronic neutropenia (SCN) is defined as an absolute neutrophil (ANC) of less than 0.5 x 10(9)/L, lasting for months or years. Congenital, cyclic, and idiopathic neutropenia are principal categories of SCN. Since 1994, the Severe Chronic Neutropenia International Registry (SCNIR) has collected data to monitor th...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.10255

    authors: Dale DC,Cottle TE,Fier CJ,Bolyard AA,Bonilla MA,Boxer LA,Cham B,Freedman MH,Kannourakis G,Kinsey SE,Davis R,Scarlata D,Schwinzer B,Zeidler C,Welte K

    更新日期:2003-02-01 00:00:00

  • Splenic lymphoma with circulating villous lymphocytes: report of seven cases and review of the literature.

    abstract::Splenic lymphoma with villous lymphocytes (SLVL) is a relatively new entity with only a few reports published. We report seven cases of SLVL with detailed clinicopathologic and comprehensive immunophenotypic studies to further characterize this lymphoma, which is frequently confused with hairy cell leukemia and other ...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.2830450107

    authors: Sun T,Susin M,Brody J,Dittmar K,Teichberg S,Weiner R,Lin JH,Felber N

    更新日期:1994-01-01 00:00:00

  • Continuous flow method for determination of erythrocyte osmotic fragility.

    abstract::A simple and accurate micromethod for the determination of erythrocyte osmotic fragility is introduced. The method uses a laminar parabolic flow pattern, together with gravity, to retain cells in a long, small-diameter tube while a solution with decreasing osmolarity is passed through the tube. As the cells hemolyze, ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830020411

    authors: Ito Y,Carmeci P,Steele R

    更新日期:1977-01-01 00:00:00

  • Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction.

    abstract::While systemic plasma endothelin-1 (ET-1) levels are increased during acute crisis in sickle cell disease, the relative levels of potent vasoactive factors that contribute to the regulation of vascular function, such as ET-1, NO, and cell-free hemoglobin, during the course of periodic vaso-occlusive episodes remain un...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20107

    authors: Ergul S,Brunson CY,Hutchinson J,Tawfik A,Kutlar A,Webb RC,Ergul A

    更新日期:2004-07-01 00:00:00

  • Erythrocyte pyruvate kinase deficiency: a kinetic method for differentiation between heterozygosity and compound-heterozygosity.

    abstract::The goal of the present study was to search for criteria that allow one to distinguish between normal individuals and heterozygotes as well as compound heterozygotes for pyruvate kinase (PK) deficiency. As the residual activity of PK with heterozygotes was between 35% and 110% of the normal activity, it was necessary ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830310402

    authors: Lakomek M,Winkler H,Linne S,Schröter W

    更新日期:1989-08-01 00:00:00

  • Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.

    abstract::Glomerular hyperfiltration and microalbuminuria/proteinuria are early manifestations of sickle nephropathy. The effects of hydroxyurea therapy on these renal manifestations of sickle cell anemia (SCA) are not well defined. Our objective was to investigate the effects of hydroxyurea on glomerular filtration rate (GFR) ...

    journal_title:American journal of hematology

    pub_type: 临床试验,杂志文章

    doi:10.1002/ajh.23365

    authors: Aygun B,Mortier NA,Smeltzer MP,Shulkin BL,Hankins JS,Ware RE

    更新日期:2013-02-01 00:00:00

  • Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia: Data from 151 patients.

    abstract::FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia (F/P+ MN-eo) is a rare disease: robust epidemiological data are lacking and reported issues are scarce, of low sample-size and limited follow-up. Imatinib mesylate (IM) is highly efficient but no predictive factor of relapse after discontinuation has yet been i...

    journal_title:American journal of hematology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/ajh.25945

    authors: Rohmer J,Couteau-Chardon A,Trichereau J,Panel K,Gesquiere C,Ben Abdelali R,Bidet A,Bladé JS,Cayuela JM,Cony-Makhoul P,Cottin V,Delabesse E,Ebbo M,Fain O,Flandrin P,Galicier L,Godon C,Grardel N,Guffroy A,Hamidou M,

    更新日期:2020-11-01 00:00:00

  • Anthracycline-based therapy of de novo acute myeloid leukemia in adults: failure of first-cycle cytoreduction to predict second-cycle outcome.

    abstract::During 1971-1988, 194 adults with de novo acute myeloid leukemia (AML) received initial therapy at the University of Minnesota with an anthracycline-based regimen. Seventy-two of the 194 required further chemotherapy and received a second cycle of the same or similar therapy; 63 of these 72 were evaluable. For each ma...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830470305

    authors: Hammerschmidt DE,Crea MT

    更新日期:1994-11-01 00:00:00

  • Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma.

    abstract::Zoledronic acid (ZOL), an intravenous bisphosphonate, has been shown to reduce and delay the incidence of skeletal-related events (SREs) in multiple myeloma (MM) patients with bone disease. A retrospective claims-based analysis was conducted that used two distinct US managed care databases to examine the relationship ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.23164

    authors: Henk HJ,Teitelbaum A,Perez JR,Kaura S

    更新日期:2012-05-01 00:00:00

  • Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients.

    abstract::Systemic light-chain (AL) amyloidosis may be associated with acquired factor X (FX) deficiency and optimal management of this coagulopathy is unknown. We reviewed our experience with 60 patients with isolated FX deficiency (< or =50%) due to AL amyloidosis that underwent an invasive procedure between 1975 and 2007. Th...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21603

    authors: Thompson CA,Kyle R,Gertz M,Heit J,Pruthi R,Pardanani A

    更新日期:2010-03-01 00:00:00

  • Properties of the exchangeable splenic platelets released into the circulation during exercise-induced thrombocytosis.

    abstract::The human spleen normally retains about one-third of the body's platelets in an exchangeable pool which can be released into the circulation by alpha-adrenergic stimulation. Some previous investigators concluded that the splenic platelet population was enriched in a subpopulation of large, young, dense platelets (mega...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830340302

    authors: Chamberlain KG,Tong M,Penington DG

    更新日期:1990-07-01 00:00:00

  • On the temporal development of erythrocyte sedimentation rate using sealed vacuum tubes.

    abstract::The temporal development of the erythrocyte sedimentation rate (ESR) was studied in wide, short vacuum tubes. It was found that in about 3% of the specimens arriving in the laboratory the ESR developed in three different phases during 60 min, whereas the other showed only two. The specimens with three phases behaved s...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830370310

    authors: Kallner A

    更新日期:1991-07-01 00:00:00

  • Effect of a single ingestion of alcohol on iron absorption.

    abstract::The effect of alcohol on inorganic and organic iron absorption was studied in 70 subjects, using a whole-body counter technique. The mean iron absorption of a test dose was 24.44%, while in the presence of whisky, absorption fell to 9.73% (P less than 0.0001). Absorption of a test dose in the presence of whisky withou...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830050307

    authors: Celada A,Rudolf H,Donath A

    更新日期:1978-01-01 00:00:00

  • CD5 positive immunoregulatory B cells in spleen populations from multiple myeloma patients.

    abstract::CD19+CD5+ lymphocytes constitute a minority of peripheral blood B cells. In view of the importance of these cells in the pathogenesis of the immunoregulation of myeloma, their incidence in another lymphoid organ was determined. CD5+ B cells were studied in 9 spleens from patients with multiple myeloma and in 10 spleen...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830370306

    authors: MacKenzie MR,Paglieroni T,Caggiano V

    更新日期:1991-07-01 00:00:00

  • Functional analysis of the marginating pool of human polymorphonuclear leukocytes.

    abstract::The intravascular pool of human polymorphonuclear leukocytes (PMN) is composed of one compartment which is circulating and another that is marginated to the vascular endothelium. Administration of B-adrenergic agonists leads to a rapid demargination with an increase in the circulating PMN pool. The marginating PMN has...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830240107

    authors: Berkow RL,Dodson RW

    更新日期:1987-01-01 00:00:00

  • High-dose methylprednisolone is an alternative treatment for adults with autoimmune thrombocytopenic purpura refractory to intravenous immunoglobulins and oral corticosteroids.

    abstract::Eight patients with severe chronic autoimmune thrombocytopenic purpura (AITP) refractory to high-dose intravenous immunoglobulin (IVIgG) and/or oral prednisone were treated with one to three infusions of high-dose methylprednisolone (HDMP) (15 mg/kg/day). The mean platelet count before treatment was 12 +/- 10 x 10(9)/...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830480416

    authors: Godeau B,Zini JM,Schaeffer A,Bierling P

    更新日期:1995-04-01 00:00:00

  • T-gamma large granular lymphocyte leukemia associated with amegakaryocytic thrombocytopenic purpura, Sjögren's syndrome, and polyglandular autoimmune syndrome type II, with subsequent development of pure red cell aplasia.

    abstract::We present a female patient with T-gamma LGL leukemia, who was followed for the last 20 years. Over these years she developed several autoimmune disorders, including Sjögren's syndrome, Hashimoto's thyroiditis, premature ovarian failure (compatible with type II autoimmune polyglandular syndrome), amegakaryocytic throm...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10024

    authors: Ergas D,Tsimanis A,Shtalrid M,Duskin C,Berrebi A

    更新日期:2002-02-01 00:00:00

  • Transplant eligibility in elderly multiple myeloma patients: Prospective external validation of the international myeloma working group frailty score and comparison with clinical judgment and other comorbidity scores in unselected patients aged 65-75 year

    abstract::Autologous stem cell transplantation (ASCT) is feasible and effective in selected older patients with Multiple Myeloma, but specific criteria for evaluating ASCT eligibility in elderly patients are lacking. We evaluated 131 patients aged 65-75 considered for ASCT at our center: The Charlson Comorbidity Index (CCI), He...

    journal_title:American journal of hematology

    pub_type: 临床试验,杂志文章

    doi:10.1002/ajh.25797

    authors: Belotti A,Ribolla R,Cancelli V,Crippa C,Bianchetti N,Ferrari S,Bottelli C,Cattaneo C,Tucci A,De La Fuente Barrigon C,Rossi G

    更新日期:2020-07-01 00:00:00

  • A subpopulation of suppressor cells in Richter's syndrome with both monocytic and T-lymphocytic characteristics.

    abstract::We evaluated T-lymphocyte functions in the peripheral blood of a patient with B-cell chronic lymphocytic leukemia after transformation to large cell lymphoma (Richter's syndrome). A subpopulation of E-rosette adherent cells were found with T-lymphocytic surface markers (OKT3+/8+/4+), monocytic characteristics (latex i...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830200312

    authors: Lahat N,Aghai E,Quitt M,Nir E,Froom P

    更新日期:1985-11-01 00:00:00

  • CD7, CD34-positive stem cell leukemia arising in agnogenic myeloid metaplasia.

    abstract::Agnogenic myeloid metaplasia (AMM) is a chronic myeloproliferative disorder arising from a single hematopoietic cell. Approximately 5% of reported cases of AMM have terminated in leukemic crisis; however, the precise characteristics of the leukemic cells have rarely been reported. We report a case of AMM that occurred...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830440111

    authors: Tasaka T,Nagai M,Murao S,Yamaguchi M,Kitanaka A,Sasaki K,Murata M,Tanaka T,Kuwabara H,Ikeda K

    更新日期:1993-09-01 00:00:00

  • Effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib-melphalan-prednisone in the phase III VISTA study.

    abstract::This analysis, using data from the bortezomib-melphalan-prednisone (VMP) arm of the Phase III VISTA study, investigated whether increased cumulative bortezomib dose could improve overall survival (OS) in transplant-ineligible patients with previously untreated multiple myeloma. Median cumulative bortezomib dose receiv...

    journal_title:American journal of hematology

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/ajh.23933

    authors: Mateos MV,Richardson PG,Dimopoulos MA,Palumbo A,Anderson KC,Shi H,Elliott J,Dow E,van de Velde H,Niculescu L,San Miguel JF

    更新日期:2015-04-01 00:00:00

  • all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia.

    abstract::all-trans-Retinoic acid (ATRA) induces complete remission in majority of patients with acute promyelocytic leukemia (APL). However, accelerated metabolism of ATRA that is induced by chronic daily administration of oral ATRA has been implicated as one of the mechanisms leading to a reduced sensitivity or resistance to ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10099

    authors: Ozpolat B,Mehta K,Tari AM,Lopez-Berestein G

    更新日期:2002-05-01 00:00:00

  • Treatment and disease-related complications in multiple myeloma: Implications for survivorship.

    abstract::New treatments have transformed multiple myeloma into a chronic disease. Hence, optimal management of treatment and disease-related complications remains a critical component of survivorship care. Survivorship care model in cancers requiring a fixed-duration therapy may not be applicable to myeloma, since patients are...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.25764

    authors: Chakraborty R,Majhail NS

    更新日期:2020-06-01 00:00:00

  • Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.

    abstract::Idiopathic thrombocytopenic purpura is an autoimmune disease which involves opsonization of platelets by autoantibodies directed against different surface glycoproteins, leading to their premature destruction by the reticuloendothelial system. Management of patients with refractory ITP is difficult. Recent studies hav...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20276

    authors: Braendstrup P,Bjerrum OW,Nielsen OJ,Jensen BA,Clausen NT,Hansen PB,Andersen I,Schmidt K,Andersen TM,Peterslund NA,Birgens HS,Plesner T,Pedersen BB,Hasselbalch HC

    更新日期:2005-04-01 00:00:00

  • Cytokine profile of sickle cell disease in Oman.

    abstract::The aim of our study was to assess the cytokine profile of sickle cell disease (SCD) patients in steady state and in vaso-occlusive crisis (VOC). VOC has a complex nature, involving interactions between sickle red blood cells (RBC), the endothelium, and leucocytes. Endothelial damage due to recurrent adhesion of sickl...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20196

    authors: Pathare A,Al Kindi S,Alnaqdy AA,Daar S,Knox-Macaulay H,Dennison D

    更新日期:2004-12-01 00:00:00

  • Deformability characteristics of sickle cells by microelastimetry.

    abstract::Deformability of normal and sickle erythrocytes was measured by means of micropipette elastimetry with determination of intrinsic membrane rigidity (P) and total cell deformability (Pt). In the elastimetric technique employed, negative pressure at the pipette tip was generated and measured continuously. Membrane rigid...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830040103

    authors: Havell TC,Hillman D,Lessin LS

    更新日期:1978-01-01 00:00:00

  • Dominantly transmitted hematologic dysfunction clinically similar to Fanconi's anemia.

    abstract::We report a family with a dominantly transmitted syndrome resembling Fanconi's anemia and spanning two generations. This syndrome was characterized by an ill-defined hematologic stem cell disorder, immune dysfunction, poor dentition, hyperpigmented skin, warts, and multiple second trimester spontaneous abortions and i...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830320402

    authors: Alter CL,Levine PH,Bennett J,Kessler C,Rick M,Washburn RG,Gallin JI,Miller RW,Auerbach AD

    更新日期:1989-12-01 00:00:00

  • Hemostatic molecular markers before the onset of disseminated intravascular coagulation.

    abstract::We retrospectively measured various hemostatic markers in 240 patients with disseminated intravascular coagulation (DIC) before the onset of DIC and in 110 non-DIC patients, and examined their usefulness for the diagnosis of pre-DIC. Changes in prothrombin time ratio and fibrinogen levels were not significant before t...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199904)60:4<273::aid-ajh4>

    authors: Wada H,Sakuragawa N,Mori Y,Takagi M,Nakasaki T,Shimura M,Hiyoyama K,Nisikawa M,Gabazza EC,Deguchi K,Kazama M,Shiku H

    更新日期:1999-04-01 00:00:00

  • Follow-up report on the 2-year cardiac data from a deferasirox monotherapy trial.

    abstract::The trial CICL670AUS04 was a single-arm, open-label study of the cardiac efficacy of 18 months of deferasirox monotherapy [1]. Cardiac response in this study was related to the degree of liver siderosis. Patients with mild to moderate liver siderosis improved their cardiac T2* while more severely siderotic patients di...

    journal_title:American journal of hematology

    pub_type: 临床试验,信件

    doi:10.1002/ajh.21830

    authors: Wood JC,Glynos T,Thompson A,Giardina P,Harmatz P,Kang BP,Paley C,Coates TD

    更新日期:2010-10-01 00:00:00

  • The prognostic value of hematogones in patients with acute myeloid leukemia.

    abstract::In acute myeloid leukemia (AML), new prognostic tools are needed to assess the risk of relapse. Hematogones (HGs) are normal B-lymphocyte precursors that increase in hematological diseases and may influence remission duration in AML. HG detection was prospectively investigated in 262 AML patients to determine its prog...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.24350

    authors: Chantepie SP,Parienti JJ,Salaun V,Benabed K,Cheze S,Gac AC,Johnson-Ansah H,Macro M,Damaj G,Vilque JP,Reman O

    更新日期:2016-06-01 00:00:00